Your browser doesn't support javascript.
loading
Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment.
Kuusalo, Laura; Venäläinen, Mikko S; Kirjala, Heidi; Saranpää, Sofia; Elo, Laura L; Pirilä, Laura.
Afiliação
  • Kuusalo L; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland. laura.kuusalo@utu.fi.
  • Venäläinen MS; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.
  • Kirjala H; Department of Medical Physics, Turku University Hospital, Turku, Finland.
  • Saranpää S; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland.
  • Elo LL; Division of Medicine, Centre for Rheumatology and Clinical Immunology, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-6, P.O. Box 52, 20521, Turku, Finland.
  • Pirilä L; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Tykistökatu 6, 20520, Turku, Finland.
Sci Rep ; 13(1): 12943, 2023 08 09.
Article em En | MEDLINE | ID: mdl-37558753
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Artrite Psoriásica / Antirreumáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Artrite Psoriásica / Antirreumáticos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article